Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1976-8-23
|
pubmed:abstractText |
Field trials involving approximately 1,250,000 chickens vaccinated with cell-free turkey herpesvirus (HVT) vaccine and 635,000 chickens vaccinated with cell-associated HVT vaccine howed both vaccines equally effective in reducing condemnations (attributable to Marek's disease) at the poultry processing plant. Vaccinated chickens were progeny of hens vaccinated at 1 day of age with cell-associated HVT vaccine. The maternal antibody did not interfere with the ability of either the cell-free or cell-associated HVT vaccine to provide protection for chickens against challenge from the virulent Marek's disease virus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0032-5791
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1868-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1975
|
pubmed:articleTitle |
Efficacy of lyophilized turkey herpesvirus vaccine against Marek's disease in broilers.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|